The Food and Drug Administration is slated to decide Thursday whether to approve the first new schizophrenia drug in at least three decades.
FDA Eyes First Schizophrenia Drug Shift in Decades
Comment
Show comments
Hide Comments
The Food and Drug Administration is slated to decide Thursday whether to approve the first new schizophrenia drug in at least three decades.
